HAN-GINS Healthcare Innovation UCITS ETF – WELL

Synopsis of Healthcare Innovation ETF

HAN-GINS Indxx Healthcare Innovation UCITS ETF (WELL) is a UCITS compliant Exchange Traded Fund domiciled in Ireland.

WELL tracks the Indxx Advanced Life Sciences & Smart Healthcare Thematic Index (Net Total Return), an index designed to measure the performance of performance of large, mid and small-capitalisation companies primarily listed on an exchange in Developed and Emerging Markets  that are involved in the Advanced Life Sciences & Smart Healthcare sector.

Please remember that the value of your investment may go down as well as up and past performance is no indication of future performance. 

Healthcare Innovation ETF (WELL) Fact Sheets

Health Innovation Market Monthly Report


Transparent, Modern Approach
WELL follows a transparent rules-based, free-float weighed index ensuring only investible companies are included within the ETF.

In a single trade, WELL provides access to a basket of companies from Developed and Emerging markets with high exposure to the healthcare innovation theme.

Unconstrained Approach
WELL transcends traditional industry and sector classifications to provide exposure to an emerging theme.

    Ticker WELL
    ISIN  IE00BJQTJ848
    TER  0.59%
    Custody Fee 0.25% (if traded via GinsGlobal)
    Inception Date  04/04/2019
    Index Indxx Advanced Life Sciences & Smart Healthcare Healthcare Thematic Index
    Domicile  Ireland
    Fund Reporting Status  Yes
    Legal Entity  UCITS
    Listings  BI, CBOE, ISE, LSE, Xetra

    Learn more about this fund at hanetf

    Please approach your intermediary or contact us directly on:

    USA (310) 432-4374 / (310) 801 4974 or 
    SA +27(0)11 8839862 / +27(0)828964234


    Index Funds - Did You Know

    Index tracking products now account for approximately 40% of the world's equity and bond assets under management.


    Pin It on Pinterest